Back to Browse Journals » Neurobehavioral HIV Medicine

Neurobehavioral HIV Medicine ceased publishing in November 2016. All new submissions can be made to HIV/AIDS - Research and Palliative Care. All articles that have been published in Neurobehavioral HIV Medicine will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.

Neurobehavioral HIV Medicine


Journal Articles:

- 38 records -

Chronic distress and the vulnerable host: a new target for HIV treatment and prevention?

Contoreggi C, Chrousos GP, Di Mascio M

Neurobehavioral HIV Medicine 2016, 7:53-75

Published Date: 28 December 2016

HIV-associated progressive multifocal leukoencephalopathy: current perspectives

Iannetta M, Zingaropoli MA, D’Abramo A, Oliva A, Mastroianni CM, Vullo V, Ciardi MR

Neurobehavioral HIV Medicine 2016, 7:43-52

Published Date: 8 August 2016

Evidence-based perspectives on the implementation of screening for neurocognitive impairment in HIV

Haddow LJ, Barber TJ, Breuer L, Cartledge JD, Pierce K

Neurobehavioral HIV Medicine 2016, 7:31-41

Published Date: 4 August 2016

Neurodevelopmental delay in pediatric HIV/AIDS: current perspectives

Blokhuis C, Kootstra NA, Caan MW, Pajkrt D

Neurobehavioral HIV Medicine 2016, 7:1-13

Published Date: 13 January 2016

Neuropsychological profile in a specific cohort of HIV patients infected postnatally: a cross-sectional study

Riva S, Cutica I, Pravettoni G

Neurobehavioral HIV Medicine 2015, 6:1-6

Published Date: 9 October 2015

Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity

Panos SE, Hinkin CH, Singer EJ, Thames AD, Patel SM, Sinsheimer JS, Del Re AC, Gelman BB, Morgello S, Moore DJ, Levine AJ

Neurobehavioral HIV Medicine 2013, 5:11-22

Published Date: 19 June 2013

Neuropsychiatric effects of tenofovir in comparison with other antiretroviral drugs

Ferrer K, Rakhmanina N

Neurobehavioral HIV Medicine 2013, 5:1-10

Published Date: 22 January 2013

Baseline medication adherence and response to an electronically delivered health literacy intervention targeting adherence

Ownby RL, Waldrop-Valverde D, Caballero J, Jacobs RJ

Neurobehavioral HIV Medicine 2012, 4:113-121

Published Date: 18 October 2012

The neuro-ophthalmology of HIV-AIDS review of Neurobehavioral HIV Medicine

Sudhakar P, Kedar S, Berger JR

Neurobehavioral HIV Medicine 2012, 4:99-111

Published Date: 18 September 2012

HIV treatment: mechanisms of neurotoxicity and implications for targeted therapy

Wu C, Lu Y

Neurobehavioral HIV Medicine 2012, 4:75-98

Published Date: 4 September 2012

Management issues in HIV-associated neurocognitive disorders

Cysique LA, Bain MP, Lane TA, Brew BJ

Neurobehavioral HIV Medicine 2012, 4:63-73

Published Date: 11 July 2012

Emerging viral and bacterial infections of the central nervous system

Balin BJ, Hammond CJ

Neurobehavioral HIV Medicine 2012, 4:35-44

Published Date: 1 May 2012

Immune activation and neuropsychiatric symptoms in human immunodeficiency virus type 1 infection

Schroecksnadel S, Kurz K, Weiss G, Fuchs D

Neurobehavioral HIV Medicine 2012, 4:1-13

Published Date: 16 January 2012

Cognitive reserve masks neurobehavioral expression of human immunodeficiency virus-associated neurological disorder in older patients

Thames AD, Foley JM, Panos SE, Singer EJ, El-Saden S, Hinkin CH

Neurobehavioral HIV Medicine 2011, 3:87-93

Published Date: 31 October 2011

A comparison of screening batteries in the detection of neurocognitive impairment in HIV-infected Spanish speakers

Levine AJ, Palomo M, Hinkin CH, Valdes-Sueiras M, Lopez E, Mathisen G, Donovan S, Singer EJ

Neurobehavioral HIV Medicine 2011, 3:79-86

Published Date: 26 September 2011

Gene expression for HIV-associated dementia and HIV encephalitis in microdissected neurons 1: preliminary analysis

Shapshak P, Duncan R, Duran EM, Farinetti F, Minagar A, Commins D, Rodriguez H, Chiappelli F, Kangueane P, Levine AJ, Singer E, Somboonwit C, Sinnott JT

Neurobehavioral HIV Medicine 2011, 3:53-78

Published Date: 19 July 2011

Expression of mannose binding lectin in HIV-1-infected brain: implications for HIV-related neuronal damage and neuroAIDS

Singh KK, Nathamu S, Adame A, Alire TU, Dumaop W, Gouaux B, Moore DJ, Masliah E, and HNRC Group

Neurobehavioral HIV Medicine 2011, 3:41-52

Published Date: 30 May 2011

Anti-HIV-1 drug toxicity and management strategies

Sharma B

Neurobehavioral HIV Medicine 2011, 3:27-40

Published Date: 28 April 2011

Depression, alcohol abuse, and disclosure of HIV serostatus among rural HIV-positive individuals in western Uganda

Nakimuli-Mpungu E, Munyaneza G

Neurobehavioral HIV Medicine 2011, 3:19-25

Published Date: 14 April 2011

Development of neurocognitive disorders in HIV/AIDS

Brandon C Dennis, Sidney A Houff, Dong Y Han, et al

Neurobehavioral HIV Medicine 2011, 3:9-18

Published Date: 10 March 2011

Effect of older age at initiation of antiretroviral therapy on patient retention in an urban ART program in Uganda

Etheldreda Nakimuli-Mpungu, Noeline Nakasujja, Howard Dickens Akena, et al

Neurobehavioral HIV Medicine 2011, 3:1-8

Published Date: 16 December 2010

Cognitive function in treated HIV patients

Valerio Tozzi, Pietro Balestra, Raffaella Libertone, et al

Neurobehavioral HIV Medicine 2010, 2:95-113

Published Date: 16 November 2010

Impact of HIV infection and alcohol on cognition: a review

Ola A Selnes

Neurobehavioral HIV Medicine 2010, 2:85-94

Published Date: 20 October 2010

Depression care and prevalence in HIV-positive individuals

Raymond L Ownby, Robin J Jacobs, Drenna Waldrop-Valverde, et al.

Neurobehavioral HIV Medicine 2010, 2:73-83

Published Date: 30 August 2010

A guide to interpretation of neuroimmunological biomarkers in the combined antiretroviral therapy-era of HIV central nervous system disease

Katrina A Morris, Nicholas WS Davies, Bruce J Brew

Neurobehavioral HIV Medicine 2010, 2:59-72

Published Date: 24 August 2010

Rates of mood and anxiety disorders and contributors to continued heroin use in methadone maintenance patients: A comparison by HIV status

Allison J Applebaum, Jacqueline R Bullis, Lara N Traeger, et al

Neurobehavioral HIV Medicine 2010, 2:49-57

Published Date: 11 August 2010

Relationships between the use of second-generation antipsychotics and changes in total cholesterol levels in children and adolescents perinatally infected with HIV

Suad Kapetanovic, Lisa Aaron, Paige L Williams, et al

Neurobehavioral HIV Medicine 2010, 2:39-48

Published Date: 4 August 2010

Amelioration of caspase 3,7 activity by SP01 in human primary neurons exposed to HIV

Amol Shah, Gursharan Chana, Ginger R Lucero, et al

Neurobehavioral HIV Medicine 2010, 2:33-37

Published Date: 14 July 2010

Exploration of a genomic expression and pathway analysis approach to neurocognitive performance: preliminary findings

Chad A Bousman, Gursharan Chana, Stephen J Glatt, et al

Neurobehavioral HIV Medicine 2010, 2:23-32

Published Date: 12 July 2010

Variable cognitive benefits in HAART-treated patients: are aging and low cholesterol linked?

María Jose Míguez-Burbano, John E Lewis, Ximena Burbano, et al

Neurobehavioral HIV Medicine 2010, 2:13-21

Published Date: 8 April 2010

Impact of COMT Val158Met on executive functioning in the context of HIV and methamphetamine

Chad A Bousman, Mariana Cherner, Stephen J Glatt, et al

Neurobehavioral HIV Medicine 2010, 2:1-11

Published Date: 14 January 2010

Alcohol use and gender effects on HIV risk behaviors in cocaine-using methadone patients

Carla J Rash, Nancy M Petry

Neurobehavioral HIV Medicine 2009, 1:25-32

Published Date: 20 November 2009

Gender and racial differences in risk factors for sexually transmitted diseases among justice-involved youth

Richard Dembo, Kristina Childs, Steven Belenko, et al

Neurobehavioral HIV Medicine 2009, 1:9-24

Published Date: 19 November 2009

CCL3 genotype and current depression increase risk of HIV-associated dementia

Andrew J Levine, Elyse J Singer, Janet S Sinsheimer, et al

Neurobehavioral HIV Medicine 2009, 1:1-7

Published Date: 17 November 2009